Indoleamine 2,3-Dioxygenase as a Prognostic Factor in Patients With Non-Small Cell Lung Cancer

Journal of Clinical & Cellular Immunology
doi 10.4172/2155-9899.1000260
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

MA11.05 Indoleamine 2,3-Dioxygenase Expression in Non-Small-Cell Lung Cancer: Analyses of Prevalence, Clinical Correlations and Prognostic Impact

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.01-10 Dyspnea as a Prognostic Factor in Hispanic Patients With Non-Small Cell Lung Cancer Cohort

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Human Immunodeficiency Virus Infection as a Prognostic Factor in Surgical Patients With Non-Small Cell Lung Cancer

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2012English

Circulating Tumor Cells as a Prognostic Factor in Patients With Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2014English

Value of the Glasgow Prognostic Score as a Prognostic Factor in Resectable Non–Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

The Hemoglobin Level as a Prognostic Factor in Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Cis-Platinum

Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
2012English

Prognostic Significance of Pigment Epithelium-Derived Factor Expression in Patients With Non-Small-Cell-Lung Cancer

Advances in Lung Cancer
2016English

Indoleamine 2,3-Dioxygenase 1 (IDO1)

Science-Business eXchange
2012English

Sex as an Independent Prognostic Factor in a Population-Based, Non-Small Cell Lung Cancer Cohort

Canadian Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy